Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.02353 | 66 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.03539 | 67 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.01758 | 66 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.35528 | 69 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.00856 | 67 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.02564 | 66 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.94484 | 65 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.01665 | 66 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.01623 | 66 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.03725 | 67 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.02273 | 67 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.02332 | 67 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.23228 | 69 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.0247 | 67 |